|Multiplexed protein profiling on microarrays by rolling-circle amplification|
B Schweitzer, S Roberts, B Grimwade, W Shao, M Wang, Q Fu, Q Shu, ...
Nature biotechnology 20 (4), 359-365, 2002
|Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1)|
A Drilon, S Siena, SHI Ou, M Patel, MJ Ahn, J Lee, TM Bauer, AF Farago, ...
Cancer discovery 7 (4), 400-409, 2017
|Catalytic and Biophysical Properties of a Nitrogenase Apo-MoFe Protein Produced by a nifB-Deletion Mutant of Azotobacter vinelandii|
J Christiansen, PJ Goodwin, WN Lanzilotta, LC Seefeldt, DR Dean
Biochemistry 37 (36), 12611-12623, 1998
|What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC)|
A Drilon, G Li, S Dogan, M Gounder, R Shen, M Arcila, L Wang, ...
Annals of Oncology 27 (5), 920-926, 2016
|Mechanistic features of the Mo-containing nitrogenase|
J Christiansen, DR Dean, LC Seefeldt
Annual review of plant biology 52 (1), 269-295, 2001
|ALK, ROS1, and NTRK rearrangements in metastatic colorectal cancer|
F Pietrantonio, F Di Nicolantonio, AB Schrock, J Lee, S Tejpar, ...
JNCI: Journal of the National Cancer Institute 109 (12), 2017
|RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients|
A Chakravarti, M Wang, HI Robins, T Lautenschlaeger, WJ Curran, ...
International Journal of Radiation Oncology* Biology* Physics 85 (5), 1206-1211, 2013
|Iron EXAFS of Azotobacter vinelandii nitrogenase molybdenum-iron and vanadium-iron proteins|
J Chen, J Christiansen, RC Tittsworth, BJ Hales, SJ George, ...
Journal of the American Chemical Society 115 (13), 5509-5515, 1993
|Spinach carbonic anhydrase: investigation of the zinc-binding ligands by site-directed mutagenesis, elemental analysis, and EXAFS|
MH Bracey, J Christiansen, P Tovar, SP Cramer, SG Bartlett
Biochemistry 33 (44), 13126-13131, 1994
|Isolation and characterization of an acetylene-resistant nitrogenase|
J Christiansen, VL Cash, LC Seefeldt, DR Dean
Journal of Biological Chemistry 275 (15), 11459-11464, 2000
|Molecular profiling of mammary analog secretory carcinoma revealed a subset of tumors harboring a novel ETV6-RET translocation|
A Skalova, T Vanecek, P Martinek, I Weinreb, TM Stevens, RHW Simpson, ...
The American journal of surgical pathology 42 (2), 234-246, 2018
|Evidence for coupled electron and proton transfer in the [8Fe-7S] cluster of nitrogenase|
WN Lanzilotta, J Christiansen, DR Dean, LC Seefeldt
Biochemistry 37 (32), 11376-11384, 1998
|Fe and Mo EXAFS of Azotobacter vinelandii nitrogenase in partially oxidized and singly reduced forms|
J Christiansen, RC Tittsworth, BJ Hales, SP Cramer
Journal of the American Chemical Society 117 (40), 10017-10024, 1995
|Mechanistic Features and Structure of the Nitrogenase α-Gln195 MoFe Protein,|
M Sørlie, J Christiansen, BJ Lemon, JW Peters, DR Dean, BJ Hales
Biochemistry 40 (6), 1540-1549, 2001
|Purification and biophysical characterization of a new [2Fe-2S] ferredoxin from Azotobacter vinelandii, a putative [Fe-S] cluster assembly/repair protein|
YS Jung, HS Gao-Sheridan, J Christiansen, DR Dean, BK Burgess
Journal of Biological Chemistry 274 (45), 32402-32410, 1999
|Development and standardization of multiplexed antibody microarrays for use in quantitative proteomics|
LT Perlee, J Christiansen, R Dondero, B Grimwade, S Lejnine, M Mullenix, ...
Proteome science 2 (1), 1-22, 2004
|Competitive substrate and inhibitor interactions at the physiologically relevant active site of nitrogenase|
J Christiansen, LC Seefeldt, DR Dean
Journal of Biological Chemistry 275 (46), 36104-36107, 2000
|Spectroscopic evidence for changes in the redox state of the nitrogenase P-cluster during turnover|
JM Chan, J Christiansen, DR Dean, LC Seefeldt
Biochemistry 38 (18), 5779-5785, 1999
|Molecular analysis of non–small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibition|
A Gualberto, M Dolled-Filhart, M Gustavson, J Christiansen, YF Wang, ...
Clinical Cancer Research 16 (18), 4654-4665, 2010
|Safety and antitumor activity of the multitargeted pan-TRK, ROS1, and ALK inhibitor entrectinib: Combined results from two phase I trials (ALKA-372-001 and STARTRK-1) Cancer …|
A Drilon, S Siena, SI Ou, M Patel, MJ Ahn, J Lee, TM Bauer, AF Farago, ...
Published by S. Karger AG, Basel www. karger. com/cro Gupta et al.: A …, 2019